
Karen Cheng
Examiner (ID: 482, Phone: (571)270-7381 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1623, 1626, 1622 |
| Total Applications | 1027 |
| Issued Applications | 720 |
| Pending Applications | 94 |
| Abandoned Applications | 236 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18141013
[patent_doc_number] => 20230014855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/755983
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755983 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | Nov 12, 2020 | Issued |
Array
(
[id] => 18093108
[patent_doc_number] => 20220411449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same
[patent_app_type] => utility
[patent_app_number] => 17/774723
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | Nov 12, 2020 | Pending |
Array
(
[id] => 18164596
[patent_doc_number] => 20230031192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => NOVEL SUBSTITUTED 6- MEMBERED HETEROARYL PIPERIDINYL ETHANONES
[patent_app_type] => utility
[patent_app_number] => 17/775985
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775985 | Substituted 6-membered heteroaryl piperidinyl ethanones | Nov 9, 2020 | Issued |
Array
(
[id] => 16657363
[patent_doc_number] => 20210053999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Tricyclic Benzoxaborole Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/089058
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089058 | Tricyclic Benzoxaborole Compounds and Uses Thereof | Nov 3, 2020 | Abandoned |
Array
(
[id] => 20315967
[patent_doc_number] => 12454509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Local anesthetics with selective-sensory nerve blockade
[patent_app_type] => utility
[patent_app_number] => 17/773171
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 21301
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773171 | Local anesthetics with selective-sensory nerve blockade | Oct 28, 2020 | Issued |
Array
(
[id] => 20535691
[patent_doc_number] => 12552755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Cinnamic amide derivative having FXR activating effect, pharmaceutical composition containing the same as active ingredient, and method for preparing the same
[patent_app_type] => utility
[patent_app_number] => 17/773349
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 9520
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773349 | Cinnamic amide derivative having FXR activating effect, pharmaceutical composition containing the same as active ingredient, and method for preparing the same | Oct 27, 2020 | Issued |
Array
(
[id] => 18146179
[patent_doc_number] => 20230020036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => TREATMENT OF EPILEPTIC CONDITIONS WITH GABAA RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/770794
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770794 | TREATMENT OF EPILEPTIC CONDITIONS WITH GABAA RECEPTOR MODULATORS | Oct 22, 2020 | Pending |
Array
(
[id] => 18093056
[patent_doc_number] => 20220411397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/770502
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770502 | ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Oct 22, 2020 | Abandoned |
Array
(
[id] => 18003435
[patent_doc_number] => 20220362201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 17/770242
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770242 | AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION | Oct 22, 2020 | Abandoned |
Array
(
[id] => 18055521
[patent_doc_number] => 20220386607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => NICOTINAMIDE COMPOUND AND HERBICIDAL COMPOSITION COMPRISING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/770681
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770681 | Nicotinamide compound and herbicidal composition comprising compound | Oct 20, 2020 | Issued |
Array
(
[id] => 17074833
[patent_doc_number] => 11111217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 17/068985
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14637
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17068985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/068985 | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | Oct 12, 2020 | Issued |
Array
(
[id] => 18065499
[patent_doc_number] => 20220396586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/761273
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761273 | THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | Sep 24, 2020 | Abandoned |
Array
(
[id] => 17563096
[patent_doc_number] => 20220127245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/428415
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428415 | Method for preparing efinaconazole using ionic liquid as medium | Sep 24, 2020 | Issued |
Array
(
[id] => 20634359
[patent_doc_number] => 12595226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/761984
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41119
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761984 | Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents | Sep 17, 2020 | Issued |
Array
(
[id] => 19090927
[patent_doc_number] => 11952357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Epoxide with low total chlorine content and no heavy metal residues and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/761501
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8204
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761501 | Epoxide with low total chlorine content and no heavy metal residues and preparation method thereof | Sep 16, 2020 | Issued |
Array
(
[id] => 17895280
[patent_doc_number] => 20220304942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => TREATMENT OF OBESITY AND RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/639013
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639013 | TREATMENT OF OBESITY AND RELATED CONDITIONS | Aug 31, 2020 | Pending |
Array
(
[id] => 18723559
[patent_doc_number] => 20230337677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/635631
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635631
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635631 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | Aug 27, 2020 | Pending |
Array
(
[id] => 17881120
[patent_doc_number] => 20220296597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => USE OF A NEUTROPHIL ELASTASE INHIBITOR IN LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/636788
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636788 | USE OF A NEUTROPHIL ELASTASE INHIBITOR IN LUNG DISEASE | Aug 20, 2020 | Abandoned |
Array
(
[id] => 17851788
[patent_doc_number] => 20220281830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => SALT
[patent_app_type] => utility
[patent_app_number] => 17/635710
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635710 | SALT | Aug 18, 2020 | Abandoned |
Array
(
[id] => 17805013
[patent_doc_number] => 20220256848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => NEO-BAVAISOFLAVONE AND COMPOSITIONS THEREOF AND THEIR USE AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 17/632751
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632751
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632751 | NEO-BAVAISOFLAVONE AND COMPOSITIONS THEREOF AND THEIR USE AS PESTICIDES | Aug 5, 2020 | Pending |